Renal carcinogenesis--insights into signaling pathways

Area of Science:

• Oncology
• Molecular Biology
• Genetics

Background:

• Renal cancer accounts for 3% of human malignancies, predominantly sporadic.
• Current research focuses on the genetic and protein basis of renal cell carcinoma (RCC).
• Translating histological subtypes to molecular understanding and identifying signaling pathway roles in pathogenesis is crucial.

Purpose of the Study:

• To review recent data on signaling pathways in renal tumor pathogenesis.
• To investigate the roles of Wnt/β-catenin, PI3K/AKT/mTOR, and HGF/cMET signaling pathways in renal cancer.
• To identify potential prognostic markers and therapeutic targets within these pathways.

Main Methods:

• Literature review of recent data on molecular pathogenesis of renal tumors.
• Focus on Wnt/β-catenin, PI3K/AKT/mTOR, and HGF/cMET signaling pathways.
• Analysis of genetic and protein alterations in renal cell carcinoma.

Main Results:

• Alterations in proto-oncogenes and tumor suppressor genes disrupt signaling pathways.
• This disruption leads to uncontrolled tumor cell proliferation and carcinogenesis.
• Specific signaling pathways like Wnt/β-catenin, PI3K/AKT/mTOR, and HGF/cMET are implicated in renal tumor development.

Conclusions:

• Signaling pathways play a critical role in the specific context of renal tumors.
• Molecules within these pathways may serve as valuable prognostic markers.
• These pathways represent promising targets for novel therapeutic strategies in renal cancer treatment.